The Side-Out Protocol is a clinical trial funded by The Side-Out Foundation. It focuses on finding effective treatment for patients with stage IV breast cancer. Stage IV is the most advanced form of breast cancer, and there is currently no cure for it.
Researchers for the Side-Out Protocol study a patient's tumor tissue using several different tumor analysis techniques to include genomic and proteomic profiling. This is called a Multi-Omic approach. The goal is to find the best treatment for each patient enrolled in the trial, and the thinking behind it is that each patient's tumor is different and will thus respond to different drugs.
Scientists and physicians hope that personalized medicine such as the Side-Out Protocol will offer the best possible treatment for each individual patient, and researchers for Side-Out's study hope their work will benefit patients who have few treatment options left.